First-in-Class Selenium-Containing Potent Serotonin Receptor 5‑HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Article in Journal of Medicinal Chemistry (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
Preprint in bioRxiv (December 2022)
DruSiLa: an integrated, in-silico disease similarity-based approach for drug repurposing
Conference proceeding (December 2022)